ANCHOR CRC: Results from a single-arm, phase II study of encorafenib plus binimetinib and cetuximab in previously untreated BRAF(V600E)-mutant metastatic colorectal cancer Journal Article

   

Authors:	Van Cutsem, E.; Taieb, J.; Yaeger, R.; Yoshino, T.; Grothey, A.; Maiello, E.; Elez, E.; Dekervel, J.; Ross, P.; Ruiz-Casado, A.; Graham, J.; Kato, T.; Ruffinelli, J. C.; André, T.; Carrière Roussel, E.; Klauck, I.; Groc, M.; Vedovato, J. C.; Tabernero, J.
Article Title:	ANCHOR CRC: Results from a single-arm, phase II study of encorafenib plus binimetinib and cetuximab in previously untreated BRAF(V600E)-mutant metastatic colorectal cancer
Journal Title:	Journal of Clinical Oncology
Volume:	42
Issue:	14
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2023-05-10
Start Page:	2628
End Page:	2637
Language:	English
DOI:	10.1200/jco.22.01693
PROVIDER:	EBSCOhost
PROVIDER:	cinahl
PUBMED:	36763936
PMCID:	PMC10414717
DOI/URL:	https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,shib&db=cin20&AN=163560154&authtype=sso&custid=s2915669&site=ehost-live&scope=site&custid=s2915669
Notes:	MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PDF -- Source: Cinahl

https://synapse.mskcc.org/synapse/works/has_related_data_chk/206968